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Clinicians make decisions for their patients everyday. Ryan Hamilton, in his course guidebook, How You Decide:
The Science of Human Decision Making, summarized the current research on the 4 R's of decision-making that
matter: reference points, reasons, resources, and replacement. The authors will apply this principle in the decisionmaking necessary for the growing Class III patients. First, the decision on whether to treat or not to treat Class III
patients in the mixed dentition rely on a thorough diagnosis and objectives for early treatment. For example,
elimination of a functional shift of the mandible may be a good reason to institute early treatment. Second, the
decision on when to start Phase II treatment relies on the follow-up observation after Phase I treatment. The
authors suggested the use of a “checklist” to decide whether patient will be benefited from surgical intervention
or nonsurgical orthodontic treatment. If the checklist review has several negative checkpoints, it will help the
clinicians to decide on an aggressive stage of 4–8 months therapeutic re-diagnosis to confirm the surgical or
nonsurgical decision.
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INTRODUCTION
Studies have shown that humans make over 30,000 decisions per day in normal lives.[1] Likewise,
orthodontists make decisions for their patients in their offices everyday. It is worthwhile for
orthodontists to understand factors involved in the human decision-making process. Ryan
Hamilton, in his course guidebook, How You Decide: The Science of Human Decision Making,
summarized the current research on this topic with the 4 R’s of decision-making that matter:
reference points, reasons, resources, and replacement.[2] The authors will apply these principles in
the decision-making necessary for the growing Class III patients.
Reference points and Class III treatment decisions
When people make decisions, losses loom larger than that of gains.[2] Gain or loss is determined
by comparing to a reference point. In the management of Class III treatment, a clinician may
choose to recommend early treatment. The reference point is a large negative Wits appraisal.
e gain would be better early function and more balanced facial esthetics. The loss, if early
treatment fails, would be a diminished trust in the clinician’s future treatment recommendations.
However, if the Class III condition that appears worse is due to a anterior functional shift rather
than a true skeletal problem, the initial reference point or the large negative Wits appraisal is not
as severe; treatment outcome will be more favorable with nonsurgical treatment.[3]
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Reasons and Class III treatment decisions

Decision-making for early Class III treatment

“When a choice for which there is no clearly superior option,
seemingly almost any reason can serve as grounds for the
choice.”[2] To treat or not to treat the early Class III condition?
Some clinicians have had bad experiences or failure when
treating Class III patients early and therefore allow growth
to proceed and postpone the treatment to a later date as a
surgical case. On the other hand, many clinicians treating
Class III patients can find reasons to recommend early
intervention such as in cases that the parents are very
concerned, as chewing seems difficult, the occlusal problem
will worsen with time, maxillary growth will respond to
orthopedic traction when the patient is younger, and the
patient is unhappy with dentofacial appearance.[4]

Class III malocclusion can be diagnosed as early as primary
dentition.[5] Young patients presented with a Class III molar
relationship, and an anterior crossbite may have a combination
of skeletal, dentoalveolar, and functional components
[Figure 1].[6] To complicate the diagnosis further, the skeletal
component of Class III malocclusions frequently has
contributions of maxillary deficiency and mandibular excess.
In addition to the apparent Angle Class III malocclusion, there
may be transverse and vertical issues that require attention.

Resources and Class III treatment decisions
The fact that people are limited in terms of attention, effort,
and self-control has two implications: first, our decisionmaking is a function of resources we have available to us.
We have different decision rules and multiple cognitive
systems that are geared toward either making fast and
easy, resource-conserving decisions or slow and deliberative,
resource-consuming decisions. We slip into the easier,
resource-conserving mode any time we are exhausted or
distracted.[2] Second, because decisions consume these
limited resources, people have become strategic in how
they spend them. Humans have developed sacrificing rules,
habitual responses, and availability heuristics.”[2]
For the growing Class III patient, then, the clinician should
make every effort to assess the “resources” and pay attention
to the plan and potential compliance of the patient and the
family. Resource assessment takes provider time and requires
effective patient education. While this can be delegated to an
experienced treatment coordinator, both patients and parents
will engage more of their “resources” if the educational
material is presented by the orthodontist who is the decisionmaker.

Functional Class III problems
Functional Class III problems can be diagnosed by checking
if there is a discrepancy between the maxilla and mandible
in centric relation and centric occlusion.[7] In addition,
patients should be evaluated in the vertical dimension for
hypodivergent or hyperdivergent growth pattern. This
diagnosis can be achieved by measuring the inclination of the
occlusal plane (OP) and the ratio of lower anterior face height
to total face height. It is notable that Class III functional shifts
may also generate an asymmetry, which if left untreated can
contribute to a true skeletal asymmetry.[8]
Early elimination of centric occlusion/centric rotation (CO/
CR) discrepancy will help in diagnosing the true underlying
skeletal problems in all three planes of space and create a
functional matrix that is more likely to lead to favorable and
balanced growth of both jaws [Figure 2].[9]
Skeletal Class III problems
Patients with no functional or CO/CR discrepancy should
also be evaluated in the vertical dimension to identify the

Replacement and Class III treatment decisions
This consideration in decision-making relates to the fact that
when people are presented with difficult tasks, they will often
replace a difficult task with a perceived easier one.[2]
For example, in Class III treatment, if a child patient finds
it difficult to wear a reverse pull headgear to the maxilla for
10–12 h a day, he/she may decline to cooperate as needed.
Through the “replacement mechanism,” the child may use his
or her limited youthful wisdom by persuading the parents
and the orthodontist to replace the reverse pull headgear
with a surgical solution even though they do not really know
what that entails and the associated risks/costs.

Figure 1: Classification of developing Class III malocclusion for
early Treatment. CO: Centric occlusion; CR: Centric relation;
LAFH: Lower anterior face height; OP: Occlusion plane inclination;
TFH: Total facial height.
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hypothesized that excess mandibular prognathism may be
related to the change in OP or Wits appraisal.
Early orthodontic or orthopedic treatment to eliminate
functional CO/CR discrepancy can be accomplished using
expansion with a partial fixed appliance, orthodontic
removable traction appliance, protraction face mask, removable
functional appliance or chincap appliance therapy, or each of
these at different stages or in combination.[14] Appliance choice
should, therefore, take into consideration available patient/
parent “resources” for the required compliance.

Figure 2: Treatment protocol for functional and skeletal Class III
patients.

growth pattern as hypodivergent or hyperdivergent. Several
authors have recommended early treatment of Class III
skeletal problems to take advantage of growth modification.
The validity of Phase II treatment is supported by studies that
show greater orthopedic effects when treatment is started
in younger patients.[10] Literature have shown that reasons
do matter because decisions by orthodontists to treat early
provide less invasive or nonsurgical treatment.[11]
With the advent of bone-anchored orthopedic device,
Class III patients with maxillary deficiency may benefit more
from early orthopedic treatment and more changes that
are favorable for children and adolescents than previously
thought.[12]
Orthopedic correction of mild and moderate skeletal
Class III conditions should be accompanied by regular
progress evaluations to avoid creating significant dental
compensations of the anterior dentition that can lead to
adverse periodontal and esthetic outcomes with reduced
long-term stability.
Poor candidates for growth modification are patients with
mandibular excess and/or vertical excess. However, Class III
malocclusions with mandibular excess seldom occur without
some components of maxillary anteroposterior (AP) and
vertical deficiency. Therefore, if maxillary AP, transverse,
and/or vertical deficiency are present, it still may be
advantageous for the patient to have an early orthopedics to
reduce the potential for these discrepancies to become worse.
The remaining mandibular growth excess can then be treated
as a one-stage/one-jaw procedure.
Longitudinal growth studies by Sugawara and Mitani showed
similar maxillary and mandibular incremental growth
change during pre-pubertal, pubertal, and post-pubertal
periods when compared with Class I subjects.[13] The authors
APOS Trends in Orthodontics • Volume 9 • Issue 2 • April-June 2019

It is important to set treatment objectives prior to initiation
of early treatment to avoid prolonged Phase I treatment time.
One of the key clinical objectives is to clearly communicate
to the parents the goals of this stage of treatment (reference
points) to achieve desired compliance and family support,
thereby preserving needed resources for future stages of
treatment.
Retention protocol is paramount after orthopedic or
orthopedic Phase I treatment to maintain early anteroposterior,
vertical, and transverse treatment results and maintain the
achieved incisor alignment.[4] Frequently, bonded lingual
arches are used to stabilize the aligned upper incisors which
preserve smile esthetics and reduce the needed for long-term
removable appliance wear, draining the patient’s “resources.”
Clinical decisions on Phase II Class III treatment
It is recommended that patients should wait until near
completion of pubertal growth spurts prior to making
decisions for Phase II treatment. In boys, it would be around
17 years and 14 years of age in girls.[14,15] In many patients,
the timing of initiation of Phase II will be determined by
the skeletal age rather than the chronologic age. During this
observation or waiting period, periodic monitoring and
communication regarding initial treatment response and
the long-term treatment objective are imperative to avoid
starting Phase II treatment before all the growth data are
assessed.
Clinicians will need to decide at that time whether the patient
can be camouflaged with orthodontic tooth movement or
wait until completion of growth for surgical treatment.
Musich developed a checklist [Figure 3] to help clinicians
in planning whether to pursue nonsurgical treatment or
surgical intervention. If the checklist review has several
negative checkpoints, it will help the clinician to decide to
proceed aggressively with a 4–8 months therapeutic diagnosis
to confirm the nonsurgical or surgical decision or accept
the fact that the best outcome can only be achieved with
surgery.[4] The authors have found that the Class III checklist
incorporates the 4 R’s of decision-making by the orthodontist
and be a useful to guide the parent (and patient) to an optimal
| 70
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indication of the stability of the initial correction, and
this is useful to illustrate to patients and to parents the
positive effect of the initial orthopedic therapy. Longterm Class III treatment requires ongoing positive
reinforcement that progress is occurring.

Figure 3: A checklist for making decision on phase II treatment for
non-surgical, surgical, or therapeutic diagnosis treatment. This is
best used for Class III patients who had Phase I treatment and there
is strong consideration to initiate Phase II treatment. The findings
of the checklist serve as a useful guide for clinician’s to choose to
continue with a non-surgical approach, or attempt an aggressive
therapeutic diagnosis with a 4-8 month re-assessment of response,
or wait for growth completion and plan Phase 11 in conjunction
with necessary jaw surgery.

course of treatment reducing the chance a overtreatment or
undertreatment. This checklist is also a good communication
tool as to help the parents and the patient understands the
reason for the decisions that are made.
The variables that enter into the analysis process make the
orthodontist’s decision extremely difficult are factored into
the Class III checklist:
• Is there a family history of mandibular prognathism?
• Does the patient’s initial diagnosis include mandibular
prognathism or is the patient’s condition primarily
due to maxillary retrusion? Note that the growth of
the maxilla is primarily sutural and can be modified,
whereas condylar growth is endochondral and is
genetically controlled.
• After following the patient for several years, what is the
growth pattern, magnitude, and direction revealed by
superimposition of growth and treatment changes.
• Is the growth pattern forward and upward or downward
and backward?
• Does the Wits appraisal become more negative as growth
proceeds, indicative of a Class III pattern dominated by
mandibular excess?
Assess treatment response using the Wits measure as a
reliable guide:
• Wits changes will serve as a horizontally corrected
growth treatment response vector.[16]
• Pre-treatment Wits compared to the reevaluation Wits
(3–4 years after initiation of treatment) will give an

Incorporate treatment response findings into recommendations
of further treatment – nonsurgical or surgical depending
on the severity of the Wits differential.[3]
• Does the superimposition of cephalograms show similar
growth in amount and direction or differential growth of
the maxilla and mandible?
• Is there additional growth that will undermine the
current outcome?
• Is the response to Phase I treatment favorable? Does the
maxilla come forward with maxillary protraction? Does
the mandible respond to chincap therapy with change in
gonial angle?
• Is the patient complying with the mechanotherapy as
needed? Are there ways to encourage great compliance
if needed? Should new “non-compliance” strategy be
introduced?
• If there is additional dental compensation available
to achieve a stable/esthetic incisal relation and will
the patient and the parents accept the facial esthetic
outcome.
• What are the limits of dental compensation on an
imbalanced Class III skeletal relationship, functionally
and esthetically and short-term and long-term?
• Will growth hormone be prescribed by the physicians?
Clinicians need to be aware of the timing of hormone
therapy and how it may impact the current maxillamandibular growth imbalance.[17]
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